<DOC>
	<DOCNO>NCT02547038</DOCNO>
	<brief_summary>Reverse hybrid therapy achieve high eradication rate bismuth quadruple therapy remain unanswered .</brief_summary>
	<brief_title>Comparing Efficacy Reverse Hybrid Therapy Bismuth Quadruple Therapy</brief_title>
	<detailed_description>A 14-day hybrid therapy invent study group appear promise H. pylorus eradication , achieve excellent eradication rate 99 % 97 % accord per-protocol intention-to-treat analysis , respectively . Recently , investigator demonstrate eradication rate reverse hybrid therapy high standard triple therapy . However , whether reverse hybrid therapy achieve high eradication rate bismuth quadruple therapy remain unanswered .</detailed_description>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Tetracycline</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Bismuth tripotassium dicitrate</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<mesh_term>Bismuth</mesh_term>
	<criteria>Consecutive H pyloriinfected outpatient , least 20 year age , endoscopically proven peptic ulcer disease gastritis previous H pylorieradication therapy ingestion antibiotic bismuth within prior 4 week patient allergic history medication use patient previous gastric surgery coexistence serious concomitant illness ( example , decompensated liver cirrhosis , uremia ) pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Helicobacter pylorus</keyword>
	<keyword>Eradication rate</keyword>
</DOC>